![Credit Card 160×600 [EN]](https://dcgreferral.com/wp-content/uploads/2024/05/US-Japan-and-German-April-Consumer-Confidence-Rebound-Orbex.webp.webp)
Similar Posts
MAD (MADUSD) Bulls Regain Control as Buying Pressure
MAD (MADUSD) Price Forecast: November 28 Despite the market crash, the MADUSD bulls regain control as buying pressure mounts at the resistance close to the overhead zone. The crypto upswing is impressive today as the coin price is trying to stabilize at the upper part of the stage. Therefore, if the coin price can sustain…
Prop Trader Confidential: Avoid This Pitfall
Prop Trader Confidential: Avoid This Pitfall There are various reasons why most prop traders fail, including inexperience, a lack of discipline, over leverage, poor risk management, lack of a trading plan, poor trading skills, inability to adapt to changing market conditions just to name a few. However, there is one rule that tilts…
US Forex Brokers Hold Over $500 Million in Client Funds, CFTC Data Shows
Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module Maximising Broker Growth with B2CORE’s IB Module In this webinar recording, Morgan Williams, Product Director at B2Core, delivers a comprehensive…
Kraken Launches Crypto-as-a-Service Tool; Adds Forex Perpetual Futures
Kraken has introduced Kraken Embed, a new Crypto-as-a-Service (CaaS) product. It is designed for neobanks, fintech companies, and traditional banks. The service allows institutions to offer cryptocurrency trading to their customers. Earlier this month, Kraken expanded beyond crypto by launching FX perpetual futures for EUR/USD and GBP/USD. Available on Kraken Pro, the new instruments allow…
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter…
Europe moves to diverge from Russian oil – WTI outlook
Today’s energy story centered on Europe’s gradual but firm shift from Russian oil. Recent headlines have circled back to the fact that some EU nations were still discreetly buying Russian barrels, prompting Trump’s blunt remark at the UN — that they are “funding the war against themselves.” Since the 2022 invasion of Ukraine, Europe’s reliance…
